Pharmaceutical investors, by the numbers
Overall, 61% of investors have at least one pharmaceutical stock in their portfolio. Of those investors, the most likely to invest in pharmaceuticals include those with a household income of $100,000-plus (71%), men (68%) and millennials (also 68%).
Noteworthy: 18% of baby boomer investors weren’t sure if there were any pharmaceutical stocks in their portfolio, while only 6% of both millennial and Gen X investors said the same.
Of those investors who have at least one pharmaceutical stock in their portfolio:
- 36% have an individual pharma-related stock they purchased
- 22% invest in a mutual fund that includes pharmaceuticals
- 16% invest in an exchange-traded fund (ETF) that includes pharmaceuticals
As for how investors decide which pharmaceutical stocks to invest in, the reasons vary:
Nearly 2 in 10 (18%) noted a financial advisor or robo-advisor makes those decisions for them. That’s especially true for baby boomers, as nearly a third (32%) who invest in pharmaceuticals said an advisor helps them select which investments to make, versus 17% of Gen Xers and 13% of millennials.